Search for: "Janssen Pharmaceutica N.V"
Results 1 - 16 of 16
Sorted by Relevance | Sort by Date
RSS Subscribe:  20 results  |  100 results
5 Sep, 2008 8:28 am by Lawrence B. Ebert
... judgment action for noninfringement against Plaintiffs-Appellees Janssen Pharmaceutica, N.V. and Janssen, L.P. (collectively Janssen). We affirm. Apotex loses. This is not a ... case to review to obtain background on the Hatch-Waxman Act. The case was about the drug respiridone: Janssen holds an approved NDA for its drug Risperdal® Oral Solution. The Orange Book originally ... it has continued since."); Int'l Med. Prosthetics Research Assocs., Inc. v. Gore Enter. Holdings, Inc., 787 F.2d 572, 575 (Fed. ...
IPBiz - http://ipbiz.blogspot.com
23 Oct 4:12 pm
... a patent is not enabled, it is invalid. In In re '318 Patent Infringement Litigation (Janssen Pharmaceutica N.V. v. Teva Pharmaceuticals USA, Inc. and related cases) (2009 U.S. App. LEXIS 21166, September 25, 2009), the Federal Circuit Court of ... thereafter, several drug companies filed abbreviated new drug applications for generic versions of galanthamine. Janssen sued these companies for patent infringement. At a bench trial, the defendants admitted infringement, but asserted ...
IP Law Blog - http://www.theiplawblog.com/
18 Aug, 2008 3:48 am by Donald Zuhn
... and pharma cases, and a few interesting cases will be selected for periodic monitoring. Janssen Pharmaceutica N.V. et al. v. Sandoz, Inc.1:08-cv-00511; filed August 13, 2008 in the District Court of Delaware Infringement of U.S. Patent No. 4,663,318 ... ) following a Paragraph IV certification as part of Sandoz's filing of an ANDA to manufacture a generic version of Janssen's Razadyne® (formerly Reminyl®) (galantamine hydrobromide, used to treat mild to moderate dementia of the ...
Patent Docs - http://patentdocs.typepad.com/patent_docs/
15 Sep, 2008 7:22 pm
... Hatch-Waxman Act as well as the impact of the Medicare Prescription Drug, Improvement and Modernization Act (MMA) passed by Congress amending the Hatch-Waxman Act. These provisions create unique issues in the context of declaratory judgment actions by potential generic drug manufacturers. More on Janssen Pharmaceutica, N.V. v. Apotex, Inc. after the jump. [More]
Filewrapper.com - http://www.Filewrapper.com/index.cfm
5 Jul, 2007 10:37 am
... 479 (Mich. 1979). To be fair, the statement in Smith was characterized as "dictum" in In re Certified Questions, 358 N.W.2d 873, 877 (Mich. 1984), but it has been followed by lower Michigan ... N.W.2d 882, 885 n.1 (Minn. 1970). Mississippi: Miss. Code §11-1-63(c)(ii); Janssen Pharmaceutica, Inc. v. Bailey, 878 So.2d 31 ... ) (product liability statute limits learned intermediary rule in strict liability). Pennsylvania: Coyle v. Richardson-Merrell, Inc., 584 A.2d 1383, 1385 (Pa. 1991); Baldino v. Castagna ...
Drug and Device Law - http://druganddevicelaw.blogspot.com
13 Aug 4:07 am by Beck/Herrmann
... filing of a petition for extraordinary ("King's Bench") review in the case of Commonwealth v. Janssen Pharmaceutica, Inc., No 0108002818 (Pa. C.P. Phila. Co.). It's ... Pennsylvania's Governor - and another $25,000 to the Democratic Governors Ass'n, of which the Governor was an officer. The Governor's Office of General Counsel ("OGC") decided ... statute creating the OGC not having any provisions authorizing contingent fees. Janssen br. at 25-27. Apparently a couple of other states have statutes allowing ...
Drug and Device Law - http://druganddevicelaw.blogspot.com
6 Aug 6:50 am by Beck/Herrmann
... we found applying the Twombly pleading standard in a drug/device product liability case. That case was Heck v. American Medical Systems, Inc., 2008 WL 1990710 (D. Md. April 30, 2008), ... Osteonics Corp., 2008 WL 141628, at *6 (D.N.J. Jan. 14, 2008). Negligence Generally Bailey v. Janssen Pharmaceutica, Inc., 288 Fed. Appx. 597, 609 (11th ... .D. Pa. 2008) (intentional infliction of emotional distress); Tyco Safety Products Canada, Ltd. v. Abracon Corp., 2008 WL 4753728, at *2 (S.D. Fla. Oct. 28, 2008) ...
Drug and Device Law - http://druganddevicelaw.blogspot.com
14 Aug 1:04 am
... we found applying the Twombly pleading standard in a drug/device product liability case. That case was Heck v. American Medical Systems, Inc., 2008 WL 1990710 (D. Md. April 30, 2008), ... Osteonics Corp., 2008 WL 141628, at *6 (D.N.J. Jan. 14, 2008). Negligence Generally Bailey v. Janssen Pharmaceutica, Inc., 288 Fed. Appx. 597, 609 (11th ... .D. Pa. 2008) (intentional infliction of emotional distress); Tyco Safety Products Canada, Ltd. v. Abracon Corp., 2008 WL 4753728, at *2 (S.D. Fla. Oct. 28, 2008) ...
DRI - http://forthedefense.org/
14 Aug 1:04 am
... we found applying the Twombly pleading standard in a drug/device product liability case. That case was Heck v. American Medical Systems, Inc., 2008 WL 1990710 (D. Md. April 30, 2008), ... Osteonics Corp., 2008 WL 141628, at *6 (D.N.J. Jan. 14, 2008). Negligence Generally Bailey v. Janssen Pharmaceutica, Inc., 288 Fed. Appx. 597, 609 (11th ... .D. Pa. 2008) (intentional infliction of emotional distress); Tyco Safety Products Canada, Ltd. v. Abracon Corp., 2008 WL 4753728, at *2 (S.D. Fla. Oct. 28, 2008) ...
DRI - http://forthedefense.org/
14 Aug 1:04 am
... we found applying the Twombly pleading standard in a drug/device product liability case. That case was Heck v. American Medical Systems, Inc., 2008 WL 1990710 (D. Md. April 30, 2008), ... Osteonics Corp., 2008 WL 141628, at *6 (D.N.J. Jan. 14, 2008). Negligence Generally Bailey v. Janssen Pharmaceutica, Inc., 288 Fed. Appx. 597, 609 (11th ... .D. Pa. 2008) (intentional infliction of emotional distress); Tyco Safety Products Canada, Ltd. v. Abracon Corp., 2008 WL 4753728, at *2 (S.D. Fla. Oct. 28, 2008) ...
DRI - http://forthedefense.org/
27 Sep 2:30 pm
... to utility (§101) for instant determination. In Re '318 Patent Infringment Litigation: Janssen Pharmaceutica v. Teva and Myland and Dr. Reddy's Laboratories and Barr ... effective filing date of the patent's application. Plant Genetic Sys., N.V. v. DeKalb Genetics Corp., 315 F.3d 1335, 1339 (Fed. ... conclusion. Finally, I disagree with the majority opinion's emphasis on the sufficiency of the evidence presented by Janssen. Because the district court erred as a matter of law and failed to make certain ...
Patent Prospector - http://www.patenthawk.com/blog/
20 Mar 2:05 am by Beck/Herrmann
... were broad enough, they tended to create legislative backlash, as happened in New Jersey. See N.J.S.A. 2A:58C-3a(1) ("state of the art" a complete defense). Drugs ... to be "clairvoyant," but rather, its judgments are evaluated "as of the time the product is distributed to the plaintiff." Toner v. Lederle Laboratories, 732 P.2d 297, 306 (Idaho 1987). The thin judicial support ... v. Farnes, 697 So.2d 825, 828 (Fla. 1997); Bailey v. Janssen Pharmaceutica, Inc., 2006 WL 3665417, at *4 (S.D. Fla. Nov. 14. ...
Drug and Device Law - http://druganddevicelaw.blogspot.com
10 Jun 10:00 pm by Beck/Herrmann
... jury could assess the link between the warnings and the injuries suffered by the consumer. . . . [N]either the Court nor a lay jury is capable of assessing the credibility of [the studies] . . . or comparing ... .3d 940 (7th Cir. 2005); Woodbury v. Janssen Pharmaceutica, Inc., 1997 WL 201571, at *9 (N.D. Ill. April 10, 1997) ("in order ... defective because of inadequate instructions or warnings requires expert testimony"). Louisiana: Sheridan v. Merck & Co., 2003 WL 22902622, at *3 (E.D. La. Dec. ...
Drug and Device Law - http://druganddevicelaw.blogspot.com
1 Oct 2:14 am by Beck/Herrmann
... " Us, Inc., 314 F. Supp.2d 177, 180-81 (S.D.N.Y. 2003) ("an unserved resident defendant may be ignored in determining removability. . . . Defendants are entitled ... of §1441(b) requires that the forum defendant be 'joined and served' to preclude removal"); Vitatoe v. Mylan Pharmaceuticals, supra, 2008 WL 3540462. On the other side of the ledger, well, that' ... last. We were all over that issue here, in our commentary about Bailey v. Janssen Pharmaceutica, Inc., 536 F.3d 1202 (11th Cir. 2008), and its ...
Drug and Device Law - http://druganddevicelaw.blogspot.com
31 May, 2007 4:31 am
... too much leeway. The backstory for the Twombly decision goes way back - fifty years to Conley v. Gibson, 355 U.S. 41 (1957). In Conley, after determining that the complaint before it was ... , Inc., 463 F. Supp.2d 496 500 (D.N.J. 2006); Bailey v. Janssen Pharmaceutica, Inc., 2006 WL 3665417, at *2 (S.D. Fla. Nov ... are unfounded "optimism," since in reality "the hope of effective judicial supervision is slim." Id. at 1967 n.6. Welcome to the club. We've been saying precisely the same thing about mass ...
Drug and Device Law - http://druganddevicelaw.blogspot.com
28 Jul 3:54 am
... Litig., 379 F. Supp.2d 348, 367-70, 432 (S.D.N.Y. 2005), where the court quoted the "no set of facts" language multiple times to ... those proceedings." 127 S.Ct. at 1967. An example of the rule in operation: Bailey v. Janssen Pharmaceutica, Inc., 288 Fed. Appx. 597 (11th Cir. 2008). Plaintiff alleged, ... even recite the contents of the warning label or to describe the manner in which the warning was inadequate. Ashcroft v. Iqbal made clear that the Twombly pleading rule applies to all civil cases, ...
Mass Tort Defense - http://www.masstortdefense.com/
         
Add to your RSS Reader Add to your Google Add to your My Yahoo Add to your My MSN Add to your My AOL Add to your Feedster Add to your Newsgator Add to your Bloglines Add to your NewsBurst Add to your Rojo Add to your Pluck